gimli

TRANSPEK stock AI analysis

TRANSPEK Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

TRANSPEK INDUSTRY LTD is a small-cap stock in Chemicals. This Gimli page shows the latest available TRANSPEK price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive TRANSPEK stock page

Price

₹1,359.40

1W return

+4.70%

1M return

+20.00%

3M return

+33.64%

6M return

n/a

1Y return

n/a

Market cap

₹759.31 cr

19.47

0.99

ROE

+5.16%

ROCE

+5.61%

RSI

54.80

Turnover

₹0.12 cr

Why it can matter in screens

Momentum: TRANSPEK is above 50DMA, below 200DMA; RSI is 54.80.
Returns: 1D +0.69%, 1W +4.70%, 1M +20.00%, 3M +33.64%, 1Y n/a.
Trend levels: 52W high ₹1,475.00, 52W low ₹952.30, off high -7.84%.
Liquidity: latest turnover is ₹0.12 cr; volume vs 20D is +0.18%.
Valuation/profitability: PE 19.47, PB 0.99, ROE +5.16%, ROCE +5.61%.
Growth: 3Y sales CAGR -9.05%, 3Y profit CAGR -18.22%.

Quick Answers

What is the latest TRANSPEK stock price?

The latest stored price for TRANSPEK is Rs 1,359.40 as of 2026-09-18.

Is TRANSPEK above its 50DMA and 200DMA?

TRANSPEK is above 50DMA, below 200DMA. The latest 50DMA is 1,228.42 and the latest 200DMA is n/a.

What are TRANSPEK PE, ROE and ROCE?

TRANSPEK has PE 19.47, ROE +5.16%, and ROCE +5.61% in Gimli's latest available snapshot.

How has TRANSPEK performed recently?

TRANSPEK has returned +20.00% over 1 month, +33.64% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	155.06 cr	24.14 cr	8.93 cr	15.99
2026-03-31	148.22 cr	22.00 cr	6.58 cr	11.78
2025-12-31	158.48 cr	28.47 cr	10.85 cr	19.42
2025-09-30	160.27 cr	31.71 cr	12.64 cr	22.62
2025-06-30	154.23 cr	35.71 cr	15.58 cr	27.90
2025-03-31	165.26 cr	39.96 cr	19.25 cr	34.39
2024-12-31	170.04 cr	28.83 cr	10.65 cr	19.06
2024-09-30	n/a	n/a	n/a	17.10

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	621.20 cr	117.89 cr	45.65 cr	nan
2025-03-31	649.85 cr	123.39 cr	48.74 cr	87.25
2024-03-31	579.63 cr	107.46 cr	38.56 cr	69.03
2023-03-31	825.65 cr	161.23 cr	83.48 cr	149.45
2022-03-31	627.49 cr	124.51 cr	65.40 cr	117.09

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	1,008.31 cr	57.83 cr	29.26 cr	767.44 cr
2025-03-31	1,000.54 cr	56.52 cr	94.45 cr	745.37 cr
2024-03-31	965.67 cr	8.08 cr	122.84 cr	673.39 cr
2023-03-31	886.87 cr	5.50 cr	144.89 cr	586.64 cr
2022-03-31	n/a	n/a	96.09 cr	n/a

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	78.47 cr	40.23 cr	n/a
2025-03-31	135.06 cr	114.22 cr	n/a
2024-03-31	97.80 cr	58.16 cr	n/a
2023-03-31	110.83 cr	61.52 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SOLARINDS	SOLAR INDUSTRIES (I) LTD	167,904.38 cr	84.314744	+35.93%	+26.94%
PIDILITIND	PIDILITE INDUSTRIES LTD	160,004.45 cr	60.281452	+25.27%	+2.95%
SRF	SRF LTD	74,457.19 cr	34.443333	+16.21%	-14.49%
COROMANDEL	COROMANDEL INTERNTL. LTD	58,928.92 cr	32.377284	+14.95%	-13.24%
LINDEINDIA	LINDE INDIA LIMITED	53,230.13 cr	96.965414	+13.58%	-3.17%
FLUOROCHEM	GUJARAT FLUOROCHEM LTD	50,384.90 cr	87.171106	+7.60%	+23.51%
FACT	FACT LTD	49,449.24 cr	-1248.718238	-2.91%	-22.73%
UPL	UPL LIMITED	48,961.82 cr	23.550659	+5.26%	-17.02%

Try these prompts

Analyze TRANSPEK INDUSTRY with valuation, momentum and industry peers
Compare TRANSPEK with other Chemicals stocks
Show small-cap stocks in Chemicals above 50DMA with positive 1M return
Find Chemicals stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-09-18. Not investment advice.